Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
92.58
+0.83 (0.90%)
At close: Dec 12, 2025, 4:00 PM EST
92.97
+0.39 (0.42%)
After-hours: Dec 12, 2025, 7:56 PM EST
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of $137.24 billion as of December 12, 2025. Its market cap has increased by 3.23% in one year.
Market Cap
137.24B
Enterprise Value
148.01B
1-Year Change
3.23%
Ranking
Category
Stock Price
$92.58
Market Cap Chart
Since December 1, 1998, Boston Scientific's market cap has increased from $10.63B to $137.24B, an increase of 1,190.81%. That is a compound annual growth rate of 9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 137.24B | 4.26% |
| Dec 31, 2024 | 131.64B | 55.44% |
| Dec 29, 2023 | 84.69B | 27.79% |
| Dec 30, 2022 | 66.27B | 9.48% |
| Dec 31, 2021 | 60.53B | 17.59% |
| Dec 31, 2020 | 51.48B | -18.33% |
| Dec 31, 2019 | 63.03B | 28.88% |
| Dec 31, 2018 | 48.90B | 43.66% |
| Dec 29, 2017 | 34.04B | 15.58% |
| Dec 30, 2016 | 29.45B | 18.74% |
| Dec 31, 2015 | 24.81B | 41.13% |
| Dec 31, 2014 | 17.58B | 9.51% |
| Dec 31, 2013 | 16.05B | 104.00% |
| Dec 31, 2012 | 7.87B | -0.56% |
| Dec 30, 2011 | 7.91B | -31.25% |
| Dec 31, 2010 | 11.51B | -15.35% |
| Dec 31, 2009 | 13.59B | 16.97% |
| Dec 31, 2008 | 11.62B | -32.97% |
| Dec 31, 2007 | 17.34B | -31.53% |
| Dec 29, 2006 | 25.32B | 26.18% |
| Dec 30, 2005 | 20.07B | -33.15% |
| Dec 31, 2004 | 30.02B | -0.30% |
| Dec 31, 2003 | 30.11B | 73.64% |
| Dec 31, 2002 | 17.34B | 78.25% |
| Dec 31, 2001 | 9.73B | 75.34% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |